Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer

184 participants · First posted Jan 27, 2025

Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)

59 participants · First posted Mar 20, 2024

PEP on a Skin Graft Donor Site Wound

8 participants · First posted Dec 11, 2020

PEP-030

PEP-6409

PEP-0102

Tissue Genesis

United States

Per Humpert

Germany

Zep Inc.

United States

Extracellular Vesicles as Next-Generation Therapeutics: Global Pipeline, Regulatory Landscape, and Translational Challenges

RION Initiates Phase 1b Trial of Exosome Therapy PEP for Knee Osteoarthritis

RION Completes Enrollment for Phase 2 Clinical Study of PEP™ in Diabetic Foot Ulcers